MEDICINAL CANNABIS IN PARKINSON DISEASE: REAL-LIFE PATIENTS’ EXPERIENCE.
Balash Y., Bar-Lev Schleider L., Korczyn AD., Shabtai H., Knaani J., Rosenberg A., Baruch Y., Djaldetti R., Giladi N,. Gurevich T.
Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272. doi: 10.1097/WNF.0000000000000246.
The aim of this interview-based study was to assess the effects of medicinal cannabis on symptoms of Parkinson disease. The results of the retrospective survey, based on interviews with 47 patients show that medicinal cannabis can improve symptoms of Parkinson disease in the initial stages.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.